Second wave anti-HCV protease inhibitors: too little too late?
- PMID: 24650101
- DOI: 10.1111/liv.12543
Second wave anti-HCV protease inhibitors: too little too late?
Comment on
-
DAUPHINE: a randomized phase II study of danoprevir/ritonavir plus peginterferon alpha-2a/ribavirin in HCV genotypes 1 or 4.Liver Int. 2015 Jan;35(1):108-19. doi: 10.1111/liv.12471. Epub 2014 Feb 12. Liver Int. 2015. PMID: 24517252 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical